ESMA blames synthetic prime, concentration risk for Archegos blow-up
The European securities regulator has said lenient capital treatment in synthetic prime brokerage was partly to blame for the Archegos implosion
Existing Subscriber?
If you are an existing subscriber please sign in to read this article in full.
Sign InSign up for a free trial
Take a complimentary trial to the FOW Marketing Intelligence Platform and gain access to a wealth of news, analysis and data across the Asset Management, Securities Finance, Custody, Fund Services and Derivatives markets.
Sign up for a free trial
